Evidence map›Paper›PMID 32717746›Full record

ArticleThe Journal of clinical endocrinology and metabolism2021

International Histopathology Consensus for Unilateral Primary Aldosteronism.

Tracy Ann Williams, Celso E Gomez-Sanchez, William E Rainey, Thomas J Giordano, Alfred K Lam, Alison Marker, Ozgur Mete, Yuto Yamazaki, Maria Claudia Nogueira Zerbini, Felix Beuschlein and 11 more

Registry-linked trialOpen access · bronzeAbstract readValidation StudyConsensus Statement
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06597630 (Pathological Type,Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism,A Prospective Study), which is not on this map. Cited by 162 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 3 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06597630 recruitingnot on this mapstarted 2023, after this paper: background citation

Pathological Type,Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism,A Prospective Study

TypeobservationalSponsorQifu LiRan2023 to 2024Enrolled100ConditionsPrimary AldosteronismArmsTissue specimens were stained by histopathology of hematoxylin-eosin
3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 3 syntheses or guidelines pooled it, 270 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. [Nature medicine · 2023
    Trial
  5. Trial
  6. Article
  7. Aldosterone-Producing Lesions HarboringHypertension (Dallas, Tex. : 1979) · 2026
    Article
  8. Article
  9. Review
  10. CT-based body composition enhances prognostic performance of PASO score for surgical outcome in primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  11. Arterial-venous adrenal embolization for aldosterone adenoma: a preliminary exploratory study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Race and Ancestry in Primary Aldosteronism.Journal of the American Heart Association · 2026
    Article
  17. Article
  18. Partial pressure of oxygen-guided adrenal venous sampling in primary aldosteronism.The Journal of clinical endocrinology and metabolism · 2026
    Article
  19. Article
  20. Primary aldosteronism.Nature reviews. Disease primers · 2026
    Review

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 10 countries.

Tracy Ann WilliamsMedizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.
Celso E Gomez-SanchezEndocrine Division, G.V. (Sonny) Montgomery VA Medical Center, and Department of Pharmacology and Toxicology and Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
William E RaineyDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Thomas J GiordanoDivision of Metabolism, Endocrine, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Alfred K LamSchool of Medicine, Griffith University, Gold Coast, Australia.
Alison MarkerDepartment of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK.
Ozgur MeteDepartment of Pathology, University Health Network, Toronto, Canada.
Yuto YamazakiDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Maria Claudia Nogueira ZerbiniDepartamento de Patologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
Felix BeuschleinMedizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.
Fumitoshi SatohDivision of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.
Jacopo BurrelloDivision of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.
Holger SchneiderMedizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.
Jacques W M LendersDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Paolo MulateroDivision of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.
Isabella CastellanoDivision of Pathology, Department of Medical Sciences, University of Turin, Turin, Italy.
Thomas KnöselInstitute of Pathology, Ludwig-Maximilians-Universität München, Germany.
Mauro PapottiDepartment of Oncology, University of Turin, Turin, Italy.
Wolfgang SaegerInstitute of Pathology, Universität Hamburg, Germany.
Hironobu SasanoDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Martin ReinckeMedizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.
LMU Klinikum · DEUniversity of Turin · ITTohoku University · JPUniversity of Michigan · USCambridge University Hospitals NHS Foundation Trust · GBGriffith University · AULudwig-Maximilians-Universität München · DERadboud University Nijmegen · NLUniversidade de São Paulo · BRUniversität Hamburg · DEUniversity Health Network · CAUniversity of Mississippi Medical Center · US

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 2016 to 2025
$38.2M
Adrenal Origins of Aldosterone ExcessR01DK106618 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI William E Rainey, Aaron Mark Udager · 2016 to 2026
$6.0M
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesisR01HL144847 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 2019 to 2022
$1.3M
Regulation of Mineralocorticoid Receptor ActionI01BX004681 · VA · G V SONNY MONTGOMERY VA MEDCIAL CENTER · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 2021 to 2023
–
BLRD VA I01 BX004681NHLBI NIH HHS R01 HL144847NIDDK NIH HHS R01 DK106618NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

objectiveDevelop a consensus for the nomenclature and definition of adrenal histopathologic features in unilateral primary aldosteronism (PA). CONTEXT: Unilateral PA is the most common surgically treated form of hypertension. Morphologic examination combined with CYP11B2 (aldosterone synthase) immunostaining reveals diverse histopathologic features of lesions in the resected adrenals. PATIENTS AND

methodsSurgically removed adrenals (n = 37) from 90 patients operated from 2015 to 2018 in Munich, Germany, were selected to represent the broad histologic spectrum of unilateral PA. Five pathologists (Group 1 from Germany, Italy, and Japan) evaluated the histopathology of hematoxylin-eosin (HE) and CYP11B2 immunostained sections, and a consensus was established to define the identifiable features. The consensus was subsequently used by 6 additional pathologists (Group 2 from Australia, Brazil, Canada, Japan, United Kingdom, United States) for the assessment of all adrenals with disagreement for histopathologic diagnoses among group 1 pathologists.

resultsConsensus was achieved to define histopathologic features associated with PA. Use of CYP11B2 immunostaining resulted in a change of the original HE morphology-driven diagnosis in 5 (14%) of 37 cases. Using the consensus criteria, group 2 pathologists agreed for the evaluation of 11 of the 12 cases of disagreement among group 1 pathologists.

conclusionThe HISTALDO (histopathology of primary aldosteronism) consensus is useful to standardize nomenclature and achieve consistency among pathologists for the histopathologic diagnosis of unilateral PA. CYP11B2 immunohistochemistry should be incorporated into the routine clinical diagnostic workup to localize the likely source of aldosterone production.

Indexed as

AdrenalectomyAdrenal GlandsAdultCohort StudiesCytochrome P-450 CYP11B2CytodiagnosisDiagnostic Techniques, EndocrineFemaleGermanyHistological TechniquesHumansHyperaldosteronismHypertensionImmunohistochemistryInternationalityMaleCytochrome P-450 CYP11B2adrenal glandCYP11B2diagnostic histopathologyimmunohistochemistryprimary aldosteronism

Identifiers

PMID32717746
PMCPMC7765663
OpenAlexW3045548795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.